Compare ETFs: IBB vs. LON:HEAL
IBB
LON:HEAL
Comparison
Average Return
In the past year, IBB returned a total of 22.61%, which is significantly higher than LON:HEAL's 13.04% return. Over the past 5 years, IBB has had annualized average returns of 1.74%, compared to -2.48% for LON:HEAL. These numbers are adjusted for stock splits and include dividends.
Top 25 Holdings
| IBB - iShares Biotechnology ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | GILD | Gilead Sciences, Inc. | 7.86% |
| 2 | AMGN | Amgen Inc. | 7.83% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 7.60% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 7.25% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 4.03% |
| 6 | ARGX | argenx SE | 3.06% |
| 7 | INSM | Insmed Incorporated | 2.99% |
| 8 | BIIB | Biogen Inc. | 2.60% |
| 9 | NTRA | Natera, Inc. | 2.32% |
| 10 | UTHR | United Therapeutics Corporation | 2.14% |
| 11 | ONC | BeOne Medicines AG | 1.94% |
| 12 | MRNA | Moderna, Inc. | 1.73% |
| 13 | INCY | Incyte Corporation | 1.72% |
| 14 | ILMN | Illumina, Inc. | 1.69% |
| 15 | RVMD | Revolution Medicines, Inc. | 1.54% |
| 16 | ROIV | Roivant Sciences Ltd. | 1.25% |
| 17 | NBIX | Neurocrine Biosciences, Inc. | 1.21% |
| 18 | GMAB | Genmab A/S | 1.19% |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 1.13% |
| 20 | BBIO | BridgeBio Pharma, Inc. | 1.12% |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.03% |
| 22 | EXEL | Exelixis, Inc. | 1.01% |
| 23 | MEDP | Medpace Holdings, Inc. | 0.99% |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 0.99% |
| 25 | ASND | Ascendis Pharma A/S | 0.96% |
| View IBB holdings | |||
| LON:HEAL - iShares Healthcare Innovation UCITS ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | MRNA | Moderna, Inc. | 2.53% |
| 2 | EBR: UCB | UCB SA | 2.35% |
| 3 | JNJ | Johnson & Johnson | 2.31% |
| 4 | ICSUAGD.IR | BlackRock ICS USD Liquidity Agency Inc | 2.30% |
| 5 | MRK | Merck & Co., Inc. | 2.21% |
| 6 | ILMN | Illumina, Inc. | 2.16% |
| 7 | BIIB | Biogen Inc. | 2.10% |
| 8 | LON: GSK | GSK plc | 2.03% |
| 9 | SWX: NOVN | Novartis AG | 1.91% |
| 10 | GILD | Gilead Sciences, Inc. | 1.89% |
| 11 | AMGN | Amgen Inc. | 1.82% |
| 12 | NTRA | Natera, Inc. | 1.80% |
| 13 | TMO | Thermo Fisher Scientific Inc. | 1.78% |
| 14 | BMY | Bristol-Myers Squibb Company | 1.78% |
| 15 | HOLX | Hologic, Inc. | 1.74% |
| 16 | SWX: ROP | Roche Holding AG | 1.73% |
| 17 | KRX: 068270 | Celltrion, Inc. | 1.71% |
| 18 | CPH: GMAB | Genmab A/S | 1.70% |
| 19 | PFE | Pfizer Inc. | 1.69% |
| 20 | ABBV | AbbVie Inc. | 1.65% |
| 21 | EW | Edwards Lifesciences Corporation | 1.64% |
| 22 | NBIX | Neurocrine Biosciences, Inc. | 1.58% |
| 23 | HKG: 6160 | BeOne Medicines AG | 1.57% |
| 24 | IQV | IQVIA Holdings Inc. | 1.56% |
| 25 | MDT | Medtronic plc | 1.51% |
| View LON:HEAL holdings | |||